JHB-17
JHB-17 is an IKKβ inhibitor with blood-brain barrier permeability, with an IC50 of 1.1 μM and a KD of 1.293 μM. JHB-17 is a non-ATP competitive inhibitor targeting the allosteric site of IKKβ, and it inhibits the phosphorylation of IKKβ. JHB-17 promotes the nuclear translocation of Nrf2, upregulates the expression of HO-1, SLC7A11 and glutathione, and reduces ROS to exert antioxidant effects. JHB-17 reduces cerebral infarction volume and improves neurobehavioral function. JHB-17 can be used in the research of cerebral ischemia-reperfusion injury.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C23H23Cl2NO3
- Masse moléculaire:432.34
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
IKKβ 1.1 μM (IC50) |
IKK-β 1.293 μM (Kd) |
HO-1 |
In Vitro
JHB-17 potently inhibits IKKβ kinase activity in a cell-free system with an IC50 of 1.1 μM, which is approximately 70 times more potent than EF24; it has a KD of 1.293 μM for binding to wild-type IKKβ, and its binding affinity to IKKβK428A and IKKβQ432A mutant proteins is reduced[1].
JHB-17 (0.625-5 μM; 1 h or 18 h) increases the survival rate of H2O2-damaged SH-SY5Y cells in a concentration-dependent manner[1].
JHB-17 (5 μM; 1 h or 18 h) significantly reduces lipid peroxidation levels (MDA levels) and ROS accumulation in SH-SY5Y cells damaged by H2O2 after 1 h or 18 h of pretreatment[1].
JHB-17 (5 μM; 6 h) promotes Nrf2 nuclear translocation[1].
JHB-17 (1.25-5 μM; 18 h) upregulates the expression of HO-1 protein in SH-SY5Y cells in a dose-dependent manner[1].
JHB-17 (5 μM; 18 h pretreatment, 6 h H2O2 exposure) inhibits H2O2-induced phosphorylation of IKKβ and upregulates the expression of HO-1 protein in SH-SY5Y cells after 18 h of pretreatment followed by 6 h of H2O2 exposure[1].
JHB-17 (5 μM; 18 h pretreatment, followed by 24 h H2O2 exposure) loses its cytoprotective effect against H2O2-induced damage in SH-SY5Y cells when IKKβ is overexpressed, which confirms that IKKβ is its key target[1].
JHB-17 acts in a dose-dependent manner, and this effect occurs after 18 h of pretreatment followed by 2 h of exposure to H2O2[1].
JHB-17 (1.25-5 μM; 18 h pretreatment, 24 h H2O2 exposure) upregulates the expression of SLC7A11, increases intracellular GSH levels and reduces lipid ROS, and inhibits H2O2-induced ferroptosis in SH-SY5Y cells in a dose-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SH-SY5Y human neuroblastoma cells (H2O2-induced oxidative damage model)
-
Concentration:0.625, 1.25, 2.5, 5 μM
-
Incubation Time:1 h or 18 h (pretreatment); 24 h (H2O2 exposure)
-
Result:Protected SH-SY5Y cells from H2O2-induced damage in a concentration-dependent manner for both 1 h and 18 h pretreatments, with significant protective activity observed at concentrations as low as 0.625 μM.
-
Cell Line:SH-SY5Y cells
-
Concentration:5 μM
-
Incubation Time:6 h
-
Result:Significantly enhanced Nrf2 fluorescence signal within the nuclei of SH-SY5Y cells, indicating increased Nrf2 nuclear translocation.
-
Cell Line:SH-SY5Y cells
-
Concentration:1.25, 2.5, 5 μM
-
Incubation Time:18 h
-
Result:Dose-dependently increased HO-1 protein levels in SH-SY5Y cells after 18 h incubation.
At 5 μM, induced stronger HO-1 expression than JHA-7 and TBHQ.
Upregulated the expression of SLC7A11.
-
Cell Line:SH-SY5Y cells (H2O2-induced oxidative damage model)
-
Concentration:5 μM
-
Incubation Time:18 h (pretreatment); 6 h (H2O2 exposure)
-
Result:Significantly inhibited H2O2-induced IKKβ phosphorylation and upregulated HO-1 protein expression in SH-SY5Y cells.
-
Cell Line:IKKβ-overexpressing SH-SY5Y cells exposed to H2O2
-
Concentration:5 μM; 1200 ng/mL IKKβ plasmid
-
Incubation Time:18 h (pretreatment); 24 h (H2O2 exposure); 6 h (transfection)
-
Result:Significantly increased cell viability after H2O2 damage in cells with normal IKKβ expression.
Almost completely abolished this protective effect in IKKβ-overexpressing cells.
Parmacokinetics
| Species | Dose | Route | T1/2 | Tmax | Cmax | AUC0-t | AUC0-∞ | MRT0-t | MRT0-∞ | F |
|---|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 15 mg/kg | i.p. | 7.57 h | 0.25 h | 56.3 ng/mL | 192.0 ng·h/mL | 205.0 ng·h/mL | 4.99 h | 7.19 h | 22.1 % |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Masse moléculaire 432.34
-
Formule C23H23Cl2NO3
-
SMILES
O=C1/C(CC/C1=C\C2=CC=C(O)C(O)=C2)=C/C3=CC=C(N(CCCl)CCCl)C=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)